GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IOL Chemicals And Pharmaceuticals Ltd (BOM:524164) » Definitions » Debt-to-Equity

IOL Chemicals And Pharmaceuticals (BOM:524164) Debt-to-Equity : N/A (As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is IOL Chemicals And Pharmaceuticals Debt-to-Equity?

IOL Chemicals And Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. IOL Chemicals And Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. IOL Chemicals And Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₹0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for IOL Chemicals And Pharmaceuticals's Debt-to-Equity or its related term are showing as below:

BOM:524164' s Debt-to-Equity Range Over the Past 10 Years
Min: 0   Med: 0.12   Max: 2.45
Current: 0.08

During the past 13 years, the highest Debt-to-Equity Ratio of IOL Chemicals And Pharmaceuticals was 2.45. The lowest was 0.00. And the median was 0.12.

BOM:524164's Debt-to-Equity is ranked better than
74.26% of 816 companies
in the Drug Manufacturers industry
Industry Median: 0.28 vs BOM:524164: 0.08

IOL Chemicals And Pharmaceuticals Debt-to-Equity Historical Data

The historical data trend for IOL Chemicals And Pharmaceuticals's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IOL Chemicals And Pharmaceuticals Debt-to-Equity Chart

IOL Chemicals And Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 - 0.03 0.05 0.02

IOL Chemicals And Pharmaceuticals Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 0.02 N/A 0.08 N/A

Competitive Comparison of IOL Chemicals And Pharmaceuticals's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IOL Chemicals And Pharmaceuticals's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where IOL Chemicals And Pharmaceuticals's Debt-to-Equity falls into.


;
;

IOL Chemicals And Pharmaceuticals Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

IOL Chemicals And Pharmaceuticals's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

IOL Chemicals And Pharmaceuticals's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


IOL Chemicals And Pharmaceuticals  (BOM:524164) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


IOL Chemicals And Pharmaceuticals Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of IOL Chemicals And Pharmaceuticals's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


IOL Chemicals And Pharmaceuticals Business Description

Traded in Other Exchanges
Address
85, Industrial Area, 'A', Ludhiana, PB, IND, 141 003
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.

IOL Chemicals And Pharmaceuticals Headlines

No Headlines